China IP Forum


In recent years, China's economy has shifted focus, moving from manufacturing toward innovation-oriented activities. Patent-related activities in China are rapidly expanding. The Chinese market is a key strategic growth area for pharmaceutical, Biotechnology and chemical companies, as well as the law firms that provide IP services to those industries. In view of these developments, we are pleased to present.

Past Events:

China 1st International Pharmaceutical & Chemical IPF

China 2nd International Pharmaceutical & Chemical IPF

Past Forum Statistics:

1st IP Forum Beijing China, 2006    Total Attendance: 280

2nd IP Forum Beijing China, 2009    Total Attendance: 320

Selected Attendance at Past IP Forum:

  • American Chemical Society (ACS)
  • Amgen Inc.
  • Biotechnology Industry Org
  • Bird & Bird
  • Chinese American Chemical Society (CACS)
  • Eli Lilly
  • Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Fitzoatrick, Cella, Harper & Scinto
  • Kim & Chang
  • Pfizer
  • Rutgers University
  • Sanofi
  • Scully Scott Murphy & Presse
  • University of Virginia
  • USA Consulate in Shanghai

  • 国家知识产权局
  • 中国食品药品监督管理局
  • 中国知识产权研究会
  • 中国工业经济联合会
  • 科技部知识产权事务中心
  • 中国石油化工股份有限公司
  • 罗氏制药中国公司
  • 北京双鹤药业股份有限公司
  • 中国专利代理(香港)有限公司
  • 柳沈律师事务所
  • 天津武田药品有限公司
  • 大连世安科技发展有限公司
  • 上海艾力斯医药科技有限公司





China International Intellectual Property Forum Committee Copyright © 2006-2019
All rights reserved.

Web designing by